journal article·2005-09

Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol)

Giyoong Tae, Julia A. Kornfield, Jeffrey A. Hubbell

Biomaterials· Volume 26· Issue 25
Publisher page

Abstract

Poly(ethylene glycol)s modified with fluorocarbon end groups are capable of in situ transition from an injectable liquid to a viscoelastic hydrogel by hydrophobic interaction of the end groups; this class of materials is useful for a variety of biomedical applications, including sustained protein release. The hydrogel state can be transformed into an injectable state by the addition of a toxicologically acceptable organic solvent, such as N-methyl pyrrolidone; after injection, this solution quickly returns to a gel state by diffusion of the water-miscible organic solvent into the surrounding environment. In vitro characterization of sustained release of human growth hormone (hGH) using this injectable depot shows that hGH remains stable inside the hydrogel formed, and demonstrates more than 2 weeks of prolonged release of hGH complexed with Zn(2+) ions without protein aggregation or initial burst.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Supramolecular Self-Assembly in Materials · Microfluidic and Capillary Electrophoresis Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (22)

Show source-provided references
1. Hubbell JA. In situ material transformations in tissue engineering. MRS Bull 1996; Nov: 33–510.1557/S0883769400031821 ↗
2. Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention10.1002/jbm.820280710 ↗
3. Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers10.1073/pnas.91.13.5967 ↗
4. Self-assembly in aqueous block copolymer solutions
5. Biodegradable block copolymers as injectable drug-delivery systems10.1038/42218 ↗
6. Dunn RL, English JP, Cowsar DR, Vanderbilt DD. Biodegradable in-situ forming implants and methods of producing the same. US Patent 5,278,202; 1994.
7. Rosenblatt J, Rhee W, Berg R. A new injectable, in-situ cross-linkable collagen biomaterials. Fifth world biomaterials congress, Toronto, Canada; 1996. p. 344.
8. Harris · 1992
9. Protein delivery from materials formed by self-selective conjugate addition reactions10.1016/S0168-3659(01)00398-4 ↗
10. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices10.1038/nbt818 ↗
11. Cell-responsive synthetic hydrogels10.1002/adma.200304621 ↗
12. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres10.1023/A:1016063109373 ↗
13. A month-long effect from a single injection of microencapsulated human growth hormone10.1038/nm0796-795 ↗
14. Sustained release of human growth hormone from PLGA solution depots10.1023/A:1018943107688 ↗
15. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO;2-9 ↗
16. A multicenter study of the efficacy and safety of sustained-release GH in the treatment of naive pediatric patients with GH deficiency10.1210/jcem.86.10.7932 ↗
17. Effect of particle-size on the in vitro and in vivo degradation rates of poly(dl-lactide-co-glycolide) microcapsules10.1002/jbm.820220806 ↗
18. In vitro biocompatibility of bioresorbable polymers: poly(L,DL-lactide) and poly(L-lactide-co-glycolide)10.1016/0142-9612(96)81421-9 ↗
19. Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein10.1021/js980065o ↗
20. Hydrogels with controlled, surface erosion characteristics from self-assembly of fluoroalkyl-ended poly(ethylene glycol)10.1021/ma0107511 ↗
21. In vivo characterization of sustained-release formulations of human growth hormone10.1016/S0022-3565(24)36732-1 ↗
22. Estimation of recombinant bovine somatotropin solubility by excluded-volume interaction with polyethylene glycols10.1023/A:1016201319136 ↗